United States (US) Oral Antiviral Market (2025-2031) | Industry, Growth, Segmentation, Analysis, Outlook, Competitive Landscape, Forecast, Trends, Size & Revenue, Value, Share, Companies

Name: United States (US) Oral Antiviral Market (2025-2031) | Trends & Outlook
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By Indication (Hepatitis, Human Immunodeficiency Virus (HIV), Influenza, Others), By Drug class (Protease inhibitors, Reverse transcriptase inhibitors, Others), By Distribution channel (Hospital pharmacies, Drug store and retail pharmacies, Online providers) And Competitive Landscape

Product Code: ETC9972255	Publication Date: Sep 2024	Updated Date: Aug 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Shubham Padhi	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

Key Highlights of the Report:

United States (US) Oral Antiviral Market Outlook
Market Size of United States (US) Oral Antiviral Market, 2024
Forecast of United States (US) Oral Antiviral Market, 2031
Historical Data and Forecast of United States (US) Oral Antiviral Revenues & Volume for the Period 2021- 2031
United States (US) Oral Antiviral Market Trend Evolution
United States (US) Oral Antiviral Market Drivers and Challenges
United States (US) Oral Antiviral Price Trends
United States (US) Oral Antiviral Porter's Five Forces
United States (US) Oral Antiviral Industry Life Cycle
Historical Data and Forecast of United States (US) Oral Antiviral Market Revenues & Volume By Indication for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oral Antiviral Market Revenues & Volume By Hepatitis for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oral Antiviral Market Revenues & Volume By Human Immunodeficiency Virus (HIV) for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oral Antiviral Market Revenues & Volume By Influenza for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oral Antiviral Market Revenues & Volume By Others for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oral Antiviral Market Revenues & Volume By Drug class for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oral Antiviral Market Revenues & Volume By Protease inhibitors for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oral Antiviral Market Revenues & Volume By Reverse transcriptase inhibitors for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oral Antiviral Market Revenues & Volume By Others for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oral Antiviral Market Revenues & Volume By Distribution channel for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oral Antiviral Market Revenues & Volume By Hospital pharmacies for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oral Antiviral Market Revenues & Volume By Drug store and retail pharmacies for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oral Antiviral Market Revenues & Volume By Online providers for the Period 2021- 2031
United States (US) Oral Antiviral Import Export Trade Statistics
Market Opportunity Assessment By Indication
Market Opportunity Assessment By Drug class
Market Opportunity Assessment By Distribution channel
United States (US) Oral Antiviral Top Companies Market Share
United States (US) Oral Antiviral Competitive Benchmarking By Technical and Operational Parameters
United States (US) Oral Antiviral Company Profiles
United States (US) Oral Antiviral Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Oral Antiviral Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Oral Antiviral Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Oral Antiviral Market - Industry Life Cycle

3.4 United States (US) Oral Antiviral Market - Porter's Five Forces

3.5 United States (US) Oral Antiviral Market Revenues & Volume Share, By Indication, 2021 & 2031F

3.6 United States (US) Oral Antiviral Market Revenues & Volume Share, By Drug class, 2021 & 2031F

3.7 United States (US) Oral Antiviral Market Revenues & Volume Share, By Distribution channel, 2021 & 2031F

4 United States (US) Oral Antiviral Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of viral infections such as herpes, influenza, and HIV in the US

4.2.2 Growing awareness about the effectiveness of oral antiviral drugs in treating viral infections

4.2.3 Technological advancements in the development of oral antiviral medications

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for the approval of oral antiviral drugs

4.3.2 Competition from generic drug manufacturers impacting pricing and market share

4.3.3 Potential side effects associated with long-term use of oral antiviral medications

5 United States (US) Oral Antiviral Market Trends

6 United States (US) Oral Antiviral Market, By Types

6.1 United States (US) Oral Antiviral Market, By Indication

6.1.1 Overview and Analysis

6.1.2 United States (US) Oral Antiviral Market Revenues & Volume, By Indication, 2021- 2031F

6.1.3 United States (US) Oral Antiviral Market Revenues & Volume, By Hepatitis, 2021- 2031F

6.1.4 United States (US) Oral Antiviral Market Revenues & Volume, By Human Immunodeficiency Virus (HIV), 2021- 2031F

6.1.5 United States (US) Oral Antiviral Market Revenues & Volume, By Influenza, 2021- 2031F

6.1.6 United States (US) Oral Antiviral Market Revenues & Volume, By Others, 2021- 2031F

6.2 United States (US) Oral Antiviral Market, By Drug class

6.2.1 Overview and Analysis

6.2.2 United States (US) Oral Antiviral Market Revenues & Volume, By Protease inhibitors, 2021- 2031F

6.2.3 United States (US) Oral Antiviral Market Revenues & Volume, By Reverse transcriptase inhibitors, 2021- 2031F

6.2.4 United States (US) Oral Antiviral Market Revenues & Volume, By Others, 2021- 2031F

6.3 United States (US) Oral Antiviral Market, By Distribution channel

6.3.1 Overview and Analysis

6.3.2 United States (US) Oral Antiviral Market Revenues & Volume, By Hospital pharmacies, 2021- 2031F

6.3.3 United States (US) Oral Antiviral Market Revenues & Volume, By Drug store and retail pharmacies, 2021- 2031F

6.3.4 United States (US) Oral Antiviral Market Revenues & Volume, By Online providers, 2021- 2031F

7 United States (US) Oral Antiviral Market Import-Export Trade Statistics

7.1 United States (US) Oral Antiviral Market Export to Major Countries

7.2 United States (US) Oral Antiviral Market Imports from Major Countries

8 United States (US) Oral Antiviral Market Key Performance Indicators

8.1 Rate of new viral infections reported in the US

8.2 Number of prescriptions for oral antiviral drugs issued by healthcare providers

8.3 Research and development investment in new oral antiviral drug formulations

9 United States (US) Oral Antiviral Market - Opportunity Assessment

9.1 United States (US) Oral Antiviral Market Opportunity Assessment, By Indication, 2021 & 2031F

9.2 United States (US) Oral Antiviral Market Opportunity Assessment, By Drug class, 2021 & 2031F

9.3 United States (US) Oral Antiviral Market Opportunity Assessment, By Distribution channel, 2021 & 2031F

10 United States (US) Oral Antiviral Market - Competitive Landscape

10.1 United States (US) Oral Antiviral Market Revenue Share, By Companies, 2024

10.2 United States (US) Oral Antiviral Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Africa Oral Antiviral Market

Estonia Oral Antiviral Market

Ethiopia Oral Antiviral Market

Fiji Oral Antiviral Market

Finland Oral Antiviral Market

Gabon Oral Antiviral Market

Global Oral Antiviral Market

Middle East Oral Antiviral Market

North America Oral Antiviral Market

Global Go To Market Strategy - 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here